Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer.
J Exp Clin Cancer Res. 2017 Jan 26;36(1):19. doi: 10.1186/s13046-016-0487-8.
J Exp Clin Cancer Res. 2017.
PMID: 28126034
Free PMC article.